We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GLSI market cap is 179.75M. The company's latest EPS is USD -0.6921 and P/E is -19.95.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.38M | -2.89M | -2.24M | -1.75M | -2.5M |
| Net Income | -2.32M | -2.79M | -2.13M | -1.63M | -2.39M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -1.86M | -4.6M | -8.04M | -9.33M |
| Net Income | -1.86M | -4.57M | -7.83M | -8.89M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 15.65M | 13.48M | 11.92M | 10.95M | 9.15M |
| Total Liabilities | 238k | 263k | 235k | 301k | 297k |
| Total Equity | 15.41M | 13.21M | 11.68M | 10.65M | 8.85M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.68M | 27.22M | 13.48M | 7M |
| Total Liabilities | 1.05M | 385k | 263k | 295k |
| Total Equity | 27.63M | 26.83M | 13.21M | 6.7M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | N/A | -6.2M | -1.56M | -2.52M | -4.32M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | -7.54M | N/A | N/A | N/A |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.15M | -4.29M | -6.2M | -6.48M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 29.81M | 2.84M | -7.54M | N/A |
| Market Cap | 179.75M |
| Price to Earnings Ratio | -19.95 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 25.39 |
| Price to Book Ratio | 26.48 |
| Dividend Yield | - |
| Shares Outstanding | 12.85M |
| Average Volume (1 week) | 32.29k |
| Average Volume (1 Month) | 36.63k |
| 52 Week Change | 23.26% |
| 52 Week High | 21.44 |
| 52 Week Low | 7.58 |
| Spread (Intraday) | 0.83 (5.74%) |
| Company Name | Greenwich LifeSciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.greenwichlifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
